ChemoCentryx, Inc.
CCXI
|
NASDAQ
|
0 Sledující
Company Quality
Profitability Score
17/100
Solvency Score
25/100
Dividends
Dividends data currently unavailable.Earnings
Earnings data currently unavailable.My Notes
You haven't added any notes for this stock yet. Use this space to record your insights or strategies.
Profile
Healthcare
Sektor
Biotechnology
Průmysl
Dr. Thomas Schall
CEO
178
Zaměstnanci
Mountain View
Centrála
US
Země
Key Metrics TTM
Valuation
Market cap.
$0Enterprise Value
-$45MPrice to Earnings
-26.46Price to Sales
0.00Price to Book
11.94Price to Cash Flow
0.00Profitability
Return on Assets
-30.32%Return on Equity
-38.43%Return on Invested Capital
-34.52%Gross Margin
99.06%Operating Margin
-417.24%Net Margin
-400.51%Liquidity
Quick Ratio
4.26Current Ratio
4.27Cash Ratio
0.79Inventory Turnover
0.35Asset Turnover
0.08Total Liabilities
N/ASolvency
Debt to Assets
0.01Debt to Equity
N/AInterest Coverage
49.89Equity Ratio
N/ALong-term Debt to Cap.
0.02Altman Z-Score
N/APerformance
Performance data currently unavailable.
Earnings Waterfall
Debt level and coverage
Debt level and coverage data currently unavailable.
Earnings
Feed
There are no posts to show right now.